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2Abstract
Objectives  In other chronic conditions, patient-specific tools with
individualized items have proven to be more sensitive outcome instruments
than fixed-item tools; their use has not yet been investigated in chronic low
back pain (cLBP).
Methods 11 males and 21 females (mean age 44.0 ± 12.3 y) with cLBP,
undergoing a spine-stabilization physiotherapy program, completed the
Roland Morris disability scale (RM) and a 0-10 pain scale pre- and post-
therapy. Post-therapy, Goal Attainment Scaling (GAS) scores were calculated
regarding achievement of 2-6 priority GAS goals established pre-therapy;
global outcome of therapy was assessed on a 5-point Likert scale.
Results Approximately one-fifth individualized goals were not covered by
items of the RM. 41/121 (34%) individualized goals were achieved at the
expected level, 42/121 (35%) were exceeded, and 38/121 (31%) were not
reached. GAS scores correlated with change scores for pain (r=0.61,
p<0.0001) and RM (r=0.49, p=0.006). 65% of the patients had a “successful
outcome” according to GAS (i.e. a score ≥ 50); 55%, according to global
outcome (=therapy helped/helped a lot); 39%, according to the RM score
change (= score decrease ≥30%); and 44%, according to the pain score
change (=score decrease ≥30%).
Conclusions GAS demonstrates the achievement of important goals
undetected by fixed-item measures and is a valid and sensitive outcome
measure for assessing the success of rehabilitation in patients with cLBP.
Key words: low back pain, outcome measures, goal attainment scaling,
physiotherapy
3Introduction
Consideration of the patient’s perspective in the planning of therapy is
associated with greater adherence (1) and increased satisfaction with care
(2). Similarly, outcome measures that are patient-centred provide the best
indication of the success of treatment. In the field of low back pain (LBP),
fixed-item condition-specific instruments such as the Oswestry Disability Index
(ODI) (3) and the Roland Morris (RM) disability questionnaire (4) are
commonly used to this end. In some fields of rehabilitation medicine, it has
been shown that wide inter-individual variability in the manifestations of a
given disorder leads to reduced responsiveness of fixed-item instruments; in
contrast, individualized outcome measures allow the achievement of
important goals to be demonstrated (5). Goal attainment scaling (GAS) (6) is
one such instrument that overcomes the “one size fits all” limitation of fixed-
item instruments by measuring program success using individualized patient
goals. The instrument has not been investigated within the context of non-
specific chronic LBP (cLBP), a condition with differing causes and associated
disability. Assessed with traditional outcome measures, the treatment of cLBP
is associated with only small to moderate effect sizes (7); this is sometimes
attributed to the failure of trials to consider the heterogeneous etiology of LBP
resulting in the group treatment effect being “diluted down” by the inclusion of
“inappropriate” patients (8). However, it is also possible that a lack of
specificity in the outcome measures is partly responsible.
This pilot study assessed the use of GAS in measuring treatment success as
compared with the RM and a pain scale after a program of physiotherapy
exercises for patients with cLBP.
4Patients and Methods
37 patients with cLBP participated in the study, which was part of a broader
investigation of various aspects of deep trunk muscle function in cLBP (9).
Briefly, the patients were enrolled into the study prior to their commencement
of a program of ‘spinal segmental stabilization exercise therapy’ in tertiary
care physiotherapy outpatient departments. They were all diagnosed by their
referring physician as having non-specific cLBP according to the diagnostic
triage reported in the current European guidelines (10). The study was
approved by the medical ethics committee of the canton of Zürich. The
patients gave their signed informed consent to participate after receiving
verbal and written information about the study.
Therapy
Twelve specially-trained physiotherapists administered the treatment
once/week for 9 weeks; it was based on the methods described by
Richardson et al (11) and involved the preferential activation of the deep
abdominal muscles, using the abdominal drawing in manoeuvre. After
mastering the basic exercise, patients integrated the deep trunk muscle
contractions into their activities of daily living/sport. Patients performed home
exercises comprising 10 repetitions, 10 times a day, documented in an
exercise diary.
5Questionnaires
Approximately 1-2 weeks before and 1-2 weeks after therapy, the patients
completed a questionnaire containing (in addition to sociodemographic,
medical and pain history questions):
• Roland and Morris disability scale (RM), which measures 24 activity
limitations due to back pain (score 0 – 24: higher score, increased
disability) (4);
• Pain Graphic Rating Scale (pain) (12) : a 0-10 scale to record average
back pain intensity during the last week.
After therapy further questions inquired about the global outcome of treatment
(“overall, how much did the treatment you received in the last few months
help?”, with a five-item Likert scale dichotomized for describing the success of
the treatment into “good outcome” (“helped”, or “helped a lot”) or “poor”
(“helped only little”, “didn’t help”, “made things worse”) (13)) and the changes
that had taken place since before therapy in relation to back pain,
independence in everyday activities, ability to do sport, general physical
capacity (at home/work), frequency and quality of social contacts, and mental
well-being (13) (response options: much better, better, unchanged, worse,
much worse).
Goal Attainment Scaling (GAS)
GAS was implemented in accordance with the original model described by
Kiresuk and Sherman (6). According to a recent systematic review, GAS
delivers reliable and valid scores when employed as an outcome measure in
working age and older people within a physical and neurological
6rehabilitation environment (14). Before therapy, two to five goals were
chosen through negotiation and consensus between the treating
physiotherapist and the patient; for each goal, five levels of possible outcome
were specified. The goals were to be specific, measurable, achievable,
realistic and timed (SMART) [Khan, 2008 #4529;Kiresuk, 1968 #4534;]. A
score of –1 indicated where the patient saw himself at baseline, i.e. pre-
treatment. After treatment each goal was examined by the corresponding
treating therapist together with the patient, and its relative achievement rated
as follows: at the expected level (=score of 0), less than expected (-1, no
change from baseline; -2, much less than baseline) or more than expected
(+1, more; +2, much more).
The scores were then converted to a GAS T-score, using the formula
provided by Kiresuk et al (15), and interpreted as follows: 50, expected level
of achievement; <50 performance below the expected level; >50
performance above the expected level.
A content analysis was carried out to investigate how many of the individual
GAS goals were reflected in the items in the RM.
Statistical analysis
Descriptive data are presented as means and standard deviations (SD), or
medians and interquartile ranges (IQR), as appropriate. Responsiveness was
given by the standardized response mean [SRM = (posttest mean – pretest
mean)/SD changes]. The relationships between GAS scores and the change
scores for RM disability and pain were examined using partial correlation
7coefficients, holding baseline values for these variables constant, as
recommended by Heavlin et al (16).
Significance was accepted at the 5% level, with no corrections for multiple
testing (17).
Results
32/37 (86%) patients completed the physiotherapy program and
questionnaires. 5 patients were considered dropouts: 2 had never actually
fulfilled the study’s admission criteria (1 language, 1 medical), and 3 chose
not to continue due to the time commitment.
The baseline characteristics and main outcome results for the 32 completers
have been reported elsewhere (9). Briefly, there were 11 men and 21 women
and their mean (SD) age was 44.0 (SD 12.3) years. They had had LBP on
average for 92 (SD 129) months, and had a RM disability score of 8.9 (SD
4.7) and an average pain intensity of 4.7 (SD 1.7). The main outcomes after
therapy comprised a 2.3-point (SD 4.2) reduction in RM disability and 1.1-
point (SD 2.1) point reduction in average pain (each p<0.01); these
constituted standardized response means (SRM) of 0.54 and 0.53
respectively (9).
In total, 134 individual goals were recorded for the whole group before
treatment began (median 4 goals/patient (IQR 2; range 2-5)). With a score of
–1 attributed to each GAS item pre-treatment, the group mean baseline GAS
score was 35.7 (SD 1.0).
The proportion of goals related to each of the RM items is shown in Table 1.
Nine RM items did not feature in any of the GAS goals. Altogether, 105/134
8(78%) goals could be matched to an RM item; those that could not tended to
be related to sporting performance, work, or psychological factors.
After therapy, it was possible to assess the level of achievement for 121 of the
original 134 goals set (goals from the drop-outs, or goals related to seasonal
sports, or influenced by subsequent musculoskeletal injuries, could not be
assessed after therapy):  41 (34%) were achieved at the expected level; 38
(31%) were not reached and 42 (35%) were exceeded.
The mean GAS score after treatment was 51.0 (SD 13.7; range 24.6-80.2).
This represented a mean change from pre-treatment of 15.3 (SD13.9), giving
a standardized response mean (SRM) for the GAS of 1.10.
The GAS scores correlated with the change in pain (corrected for baseline
pain; partial r=0.61, p<0.0001) and RM (corrected for baseline disability;
partial r=0.49, p=0.006), and with the post-therapy ratings of global treatment
effectiveness (corrected Rho=0.39, p=0.034). They also showed low but
significant correlations with the post-therapy ratings of improvement in the
domains back pain, independence, ability to do sport, and mental well-being
(Table 2).
The proportions of patients achieving a minimum 30% reduction in RM and in
pain (i.e., clinically relevant changes (18)) were 39% and 44% respectively.
The global outcome was rated as “good” (=therapy helped/helped a lot) in
55% patients. 64.5% patients achieved their goals or more, as judged by a
GAS score ≥ 50.
9Discussion
A major challenge in the evaluation of treatment outcome is the identification
of methods that adequately measure the success of a program. Clinicians
have long sought standardized tests against which an entire patient
population can be measured; equally, however, such measures are criticized
for being insensitive to the uniqueness of the goals of each patient within a
given program (19). Overall, the findings of the present study supported those
in other fields of rehabilitation, namely that there was a moderate correlation
between the scores given by the fixed-item and patient-specific measures
(suggesting adequate construct validity for the GAS), but that GAS was more
responsive to change after treatment than were the fixed-item instruments.
Following the methods reported in previous studies on GAS (e.g., (5,20)) and
for the purposes of comparison, we assessed the instrument’s
responsiveness using the standardized response mean (SRM) (whilst mindful
of the objections to doing so (6)). Encouragingly, the conclusions based on
the SRMs (i.e., that GAS was the most responsive instrument) were wholly
substantiated by those based on non-parametric methods of inferential
analysis, such as frequency analysis of the proportion of patients with a
successful outcome. It was established that almost two-thirds (65%) patients
had a GAS score ≥ 50, indicating that they had achieved or exceeded their
goals, whereas only approximately 40% patients achieved the minimum
clinically important change of a 30% reduction in score for pain or disability,
and 55% reported a “good global outcome”. Hence, GAS does indeed appear
to demonstrate the achievement of important goals that are less well detected
by fixed-item measures.
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We attempted to examine the content validity of GAS by performing a
qualitative content analysis of the individual goals declared pre-treatment. At
face value, the goals appeared to be typical of those commonly identified in
normal clinical practice for patients of this type. Also, most of the goals were
approximated by the items of the RM, an instrument devised on the basis of
typical complaints in a large group of LBP patients in primary care (4). It was
interesting that 22% of the goals set using the GAS — most notably those to
do with sports, work, or psychological manifestations of the pain — could not
be linked to any items of the RM, even in their broadest context of
understanding. This highlights one of the benefits of GAS, i.e., it is able to
obtain a comprehensive record of items that are important to the patient,
regardless of how ambitious they may appear to be on an “average patient”
basis. Interestingly, many of the goals, although expressed in terms of
“function”, were actually placed within a context of pain; this might explain why
the GAS score correlated better with improvements in pain than with
improvements in RM score. Despite what we might like to think or hope, it
would seem that it is still the level of pain that is most important to these
patients.
One of the potential disadvantages of GAS is that clinicians require sufficient
knowledge, training and experience to carry out the procedure of goal-setting.
Nonetheless, the various steps in the process are all well documented (15).
The GAS formula is designed such that if goal achievement is predicted
accurately and in an unbiased manner, the GAS at outcome should exceed
and fall short of expectations in roughly equal proportions, and there should
be an approximately normal distribution of GAS T-scores with a mean of 50
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and SD of ±10 (6). This was the case in the present study (GAS score 51 ±
14, range 25-80) suggesting there was no or little bias in estimating the
potential for gain, and providing some support for the validity of the method
applied. To the authors’ knowledge, the impact of the actual number of goals
set on the subsequent GAS scores has not been investigated in detail, and
within the confines of the present study we could not shed any further light on
this. The use of more than 2 goals is reported to deliver more reliable scores,
as is the use of a 5-point rather than 3-point scale for rating their
achievement, but the number set must also be considered in relation to the
length and scope of the programme and the needs of the patient (15).  We
were also unable to assess the test-retest reliability of the GAS scores in the
present study; however, a recent systematic review has testified to the
reliability of GAS when employed as an outcome measure in other physical
rehabilitation settings (14).
Another possible limitation of GAS as an outcome instrument is that it is
designed for assessing the effectiveness of treatment after a designated
period of time only. In many instances, however, it is desirable to follow-up
patients for longer to see how well any treatment effect is maintained. For this,
the serial application of fixed-item instruments, which simply focus on “current
status” at each assessment, are required.  GAS scores also tell us nothing
about the absolute level of adjustment or disability of the individual.
Important decisions regarding the quality of therapy and health policy are
based on patient outcomes, and so it is essential to identify the most
appropriate assessment tool. Our findings lead us to concur with previous
authors (5,20) that, in addition to documenting pre-treatment expectations on
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change and sharpening the focus of treatment, GAS is able to capture subtle
but important change in client-centered functioning. It appears more suited to
complement rather than replace established outcome measures — since both
have their own unique advantages and disadvantages — and will perhaps
have more relevance in one setting than in another. However, overall, GAS
should be considered a useful adjunct to the present fixed-item options for
assessing patient outcomes after rehabilitation for chronic LBP.
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Table 1. Frequency of items in the Roland Morris disability
questionnaire that featured as the “area to be addressed” in the
individual’s goals.
RM
item
no.
Count Count %
2 I change position frequently to try and get my back
comfortable
21 15.7
10 I only stand up for short periods of time because of my back. 15 11.2
11 Because of my back I try not to bend or kneel down. 15 11.2
4 Because of my back I am not doing any of the jobs that I
usually do around the house.
13 9.7
21 I avoid heavy jobs around the house because of my back. 11 8.2
17 I only walk short distances because of my pain. 9 6.7
13 My back is painful almost all the time. 5 3.7
18 I sleep less well because of my back. 5 3.7
14 I find it difficult to turn over in bed because of my back. 3 2.2
23 Because of my back pain, I am more irritable and bad
tempered with people than usual.
3 2.2
12 I find it difficult to get out of a chair because of my back. 2 1.5
16 I have trouble putting on my socks (or stockings) because of
the pain in my back.
1 0.8
5 Because of my back I use a handrail to get upstairs. 1 0.8
3 I walk more slowly than usual because of my back 1 0.7
1 I stay at home most of the time because of my back 0 0
6 Because of my back I lie down to rest more often. 0 0
7 Because of my back I have to hold on to something to get
out of an easy chair.
0 0
8 Because of my back I try to get other people to do things for
me.
0 0
9 I get dressed more slowly than usual because of my back. 0 0
15 My appetite is not very good because of my back pain. 0 0
19 Because of my back pain I get dressed with help from
someone else.
0 0
20 I sit down for most of the day because of my back. 0 0
24 Because of my back I go upstairs more slowly than usual. 0 0
- ----------------------------------------------------------------------------- 29 21.8
TOT 134 100%
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Table 2. Spearman Rank correlation coefficients between the global
improvements in each domain measured post-therapy and the GAS scores,
the change scores for pain, and change scores for RM disability.
Change score
Ave LBP
Change score
RM
GAS score
Global improvement in
pain
0.51 0.49 0.44
Global improvement in
independence
0.59 0.54 0.40
Global improvement in
ability to do sport
0.48 0.66 0.43
Global improvement in
physical activities in
general
0.46 0.50 0.33
Global improvement in
quality/quantity social
contacts
0.13 -0.02 0.01
Global improvement in
mental well-being
-0.25 -0.08 -0.40
Values in bold are p<0.05
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Key messages
• Important decisions regarding therapy and health policy are based on
patient outcomes.
• GAS is able to capture subtle but important changes in functioning in
patients with LBP.
• GAS appears more suited to complement rather than replace
established fixed-item outcome measures.
